Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with Trichuris trichiura: A Randomized, Controlled Superiority Trial.

MLA

Sprecher, Viviane P., et al. “Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with Trichuris Trichiura: A Randomized, Controlled Superiority Trial.” Clinical Infectious Diseases, vol. 77, no. 9, Nov. 2023, pp. 1294–302. EBSCOhost, https://doi.org/10.1093/cid/ciad387.

APA

Sprecher, V. P., Coulibaly, J. T., Hürlimann, E., Hattendorf, J., & Keiser, J. (2023). Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with Trichuris trichiura: A Randomized, Controlled Superiority Trial. Clinical Infectious Diseases, 77(9), 1294–1302. https://doi.org/10.1093/cid/ciad387

Chicago

Sprecher, Viviane P, Jean T Coulibaly, Eveline Hürlimann, Jan Hattendorf, and Jennifer Keiser. 2023. “Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with Trichuris Trichiura: A Randomized, Controlled Superiority Trial.” Clinical Infectious Diseases 77 (9): 1294–1302. doi:10.1093/cid/ciad387.